0001680048-17-000004.txt : 20170412
0001680048-17-000004.hdr.sgml : 20170412
20170412124552
ACCESSION NUMBER: 0001680048-17-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170412
DATE AS OF CHANGE: 20170412
EFFECTIVENESS DATE: 20170412
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUSTANG BIO, INC.
CENTRAL INDEX KEY: 0001680048
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473828760
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0312
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-284600
FILM NUMBER: 17757502
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 7816524507
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
D
1
primary_doc.xml
X0707
D
LIVE
0001680048
MUSTANG BIO, INC.
2 GANSEVOORT STREET
9TH FLOOR
NEW YORK
NY
NEW YORK
10014
7816524507
DELAWARE
Mustang Therapeutics, Inc.
None
Corporation
true
2015
Michael
S.
Weiss
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Executive Officer
Director
Lindsay
A.
Rosenwald
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
Neil
Herskowitz
c/o 2 Gansevoort Street
9th Floor
New York
NY
NEW YORK
10014
Director
Biotechnology
Decline to Disclose
- 06b
false
2017-03-31
false
true
true
false
0
National Securities Corporation
7569
National Securities Corporation
7569
410 Park Avenue
14th Floor
New York
NY
NEW YORK
10022
All States
false
416000
416000
0
false
7
45600
0
In addition to the cash commission above, Issuer also issued warrants to purchase a number of shares of the Issuer's Common Stock equal to 10% of the aggregate amount of shares into which the Notes sold in the offering eventually are convertible.
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
MUSTANG BIO, INC.
/s/ Michael S. Weiss
Michael S. Weiss
President and Chief Executive Officer
2017-04-12